All In MedTech

Company

Auris Health

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $205M raised of $220M sought, first sale Nov 13, 2018, 22 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Nov 13, 2018Equity$205M$220M22Rule 506(b)Agent: Allen & Company LLCCommissions $4.5MForm D ↗Nov 28, 2018

Company details

From the company's latest Form D.

Legal name
AURIS HEALTH, INC.
Headquarters
Redwood City, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Technology

Executives, directors and promoters

As listed on the latest Form D.

    6 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

    No 5%+ shareholder filings, SBIR grants or venture investors found under the name Auris Health.

    Latest FDA decisions

    Search the Clearance Tracker

    7 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT06709261 · 32 participants · Start Feb 5, 2025 · Primary completion Oct 20, 2025

      Device: OTTAVA Robotic System · For: Obesity

      Sites: Orlando, Florida; Tampa, Florida; Indianapolis, Indiana · 6 sites in all

    7 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230700
    Jan 243100
    Feb 241300
    Mar 241500
    Apr 240100
    May 240300
    Jun 240300
    Jul 242200
    Aug 241000
    Sep 242000
    Oct 243100
    Nov 241000
    Dec 244000
    Jan 250100
    Feb 250210
    Mar 250300
    Apr 250800
    May 250300
    Jun 251400
    Jul 250000
    Aug 250400
    Sep 250200
    Oct 2512100
    Nov 251110
    Dec 250400
    Jan 262200
    Feb 2601010
    Mar 261200
    Apr 260300
    May 261800
    Jun 261500
    Jul 260100
    Aug 260100
    Sep 260100
    Oct 260100
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    The full in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    2 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    7 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.